Combivent provide the simultaneous release of ipratropium bromide and salbutamol sulphate allowing the additive effect on both muscarinic and beta2-adrenergic receptors in the lung resulting in a bronchodilation, which is superior to that provided by each single agent.
藥動學
禁忌症
Hypertrophic obstructive cardiomyopathy; tachyarrythmia; Hypersensitivity to ipratropium, salbutamol, atropine or any components of the product.
懷孕分類
C
哺乳分類
Avoided
副作用
headache, dizziness, nervousness, tachycardia, fine tremor of skeletal muscles and palpitations, dryness of the mouth and dysphonia.
劑量和給藥方法
Adults: 1 unit-dose vial nebulization 4 times daily, MAX 6 doses/day